Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: To identify the prevalence of non-bronchial systemic culprit arteries and their relationship to bleeding lobes in patients with hemoptysis with bronchiectasis and chronic pulmonary infection who underwent de novo bronchial artery embolization (BAE).

Methods: Data of 83 consecutive patients with bronchiectasis and chronic pulmonary infection (non-tuberculous mycobacteriosis, aspergillosis, and tuberculosis) who underwent de novo BAE between January 2019 and December 2020 were retrospectively reviewed. The prevalence of culprit arteries was investigated.

Results: Fifty-five patients (66%) had 172 non-bronchial systemic culprit arteries. The bleeding lobes were the right upper, right middle, right lower, left upper, and left lower lobes in 14 (17%), 20 (24%), 7 (8%), 31 (37%), and 11 (13%) patients, respectively. The internal thoracic (49%; n = 41), intercostal (28%; n = 23), and inferior phrenic (28%; n = 23) arteries were the top three non-bronchial systemic culprit arteries, which were involved in all five types of bleeding lobes. The costocervical trunk and thoracoacromial and lateral thoracic arteries were predominant in patients with upper lobe bleeding. Ligament arteries were predominant in patients with left lower lobe bleeding.

Conclusions: These findings will better ensure the identification of non-bronchial systemic culprit arteries in patients with hemoptysis with bronchiectasis and chronic pulmonary infection. All systemic arteries, especially those which are adjacent to the lung lesions, should be evaluated carefully using MDCT; the internal thoracic, intercostal, and inferior phrenic arteries should be proactively assessed using angiography.

Key Points: • Non-bronchial systemic culprit arteries were identified in 66% of patients with hemoptysis with bronchiectasis and chronic pulmonary infection who underwent de novo bronchial artery embolization. • The internal thoracic (49%), intercostal (28%), and inferior phrenic (28%) arteries were the top three arteries, which were involved in all five types of bleeding lobes. • The costocervical trunk and thoracoacromial and lateral thoracic arteries were prominent in patients with upper lobe bleeding, and the ligament artery was prominent in patients with left lower lobe bleeding.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-022-09310-4DOI Listing

Publication Analysis

Top Keywords

culprit arteries
28
non-bronchial systemic
24
systemic culprit
24
bronchiectasis chronic
20
chronic pulmonary
20
pulmonary infection
20
patients hemoptysis
16
hemoptysis bronchiectasis
16
underwent novo
16
bleeding lobes
16

Similar Publications

Reconsidering Electrocardiographic Predictors of Culprit Coronary Artery Occlusion in NSTEMI Patients.

Ann Noninvasive Electrocardiol

September 2025

Department of Cardiology, Faculty of Medicine, Hitit University, Corum, Turkey.

This letter provides a critical appraisal of the study by Wei et al. on clinical and electrocardiographic predictors of left circumflex artery occlusion in NSTEMI patients. While the authors identified STV5 + STV6 ≥ 2.

View Article and Find Full Text PDF

Cerebral small-vessel disease (CSVD) is an important risk factor for cognitive impairment, which is a pressing health issue for the aging population worldwide. The complex relationship between vascular factors, such as blood pressure variability (BPV) and arteriosclerosis index (AI), and cognitive dysfunction in patients with CSVD is a hot research topic, and research in this area will help prevent and treat cognitive dysfunction in CSVD. This study aims to investigate the effects of diastolic BPV (DBPV) and AI on cognitive function in patients with CSVD.

View Article and Find Full Text PDF

From Cushion to Culprit: The Role of Epicardial Adipose Tissue in Cardiovascular Disease.

Heart Lung Circ

September 2025

Baker Heart and Diabetes Institute, Melbourne, Vic, Australia; Victorian Heart Hospital, Melbourne, Vic, Australia; Victorian Heart Institute, Melbourne, Vic, Australia. Electronic address:

Epicardial adipose tissue (EAT) is the layer of fat located between the visceral pericardium and the myocardium. Emerging research has signified its role in the development of various cardiovascular diseases. The pathogenesis is complex, involving various bioactive compounds that have been implicated in the development of coronary artery disease, heart failure, and arrhythmogenesis.

View Article and Find Full Text PDF

Background: The optimal timing of complete revascularisation for patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains unclear. We aimed to assess whether immediate complete revascularisation was non-inferior to staged complete revascularisation during the index admission.

Methods: We conducted an open-label, randomised, non-inferiority trial at 14 hospitals in South Korea.

View Article and Find Full Text PDF

Association between residual cholesterol and vulnerable non-culprit lesions progressing to major adverse cardiovascular events.

Front Endocrinol (Lausanne)

September 2025

Department of Children's Heart Center, Fuwai Central China Cardiovascular Hospital, Zhengzhou University Central China Fuwai Hospital, Zhengzhou, China.

Background: Residual cholesterol (RC), a key indicator of lipid metabolism disorders, has been increasingly implicated in atherosclerotic progression. However, its association with vulnerable thin-cap fibroatheromas (TCFA) in non-culprit coronary lesions (NCCLs) and the subsequent risk of major adverse cardiovascular events (MACE) remains insufficiently explored.

Methods: In this prospective observational study conducted between June 2022 and September 2023, patients diagnosed with TCFA within NCCLs were followed for at least 12 months.

View Article and Find Full Text PDF